The Relationship Between Glycemic Control and Concomitant Hypertension on Arterial Stiffness in Type II Diabetes

References

• Standl E, Khunti K, Hansen TB, Schnell O. The global epidemics of diabetes in the 21st century: current situation and perspectives. Eur J Prev Cardiol. 2019;26(2_suppl):7–14. doi:10.1177/2047487319881021
   PubMed Web of Science ®Google Scholar
• Goff DC Jr., Gerstein HC, Ginsberg HN, et al. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007;99(12a):4i–20i. doi:10.1016/j.amjcard.2007.03.002
   PubMed Web of Science ®Google Scholar
• Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–2222. doi:10.1016/S0140-6736(10)60484-9.
   PubMed Web of Science ®Google Scholar
• Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Type 2 diabetes as a “coronary heart disease equivalent”: an 18-year prospective population-based study in Finnish subjects. Diabetes Care. 2005;28(12):2901–2907. doi:10.2337/diacare.28.12.2901
   PubMed Web of Science ®Google Scholar
• Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation. 2013;127(1):143–152. doi:10.1161/CIR.0b013e318282ab8f
   PubMed Web of Science ®Google Scholar
• Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34(5):575–584. doi:10.1016/j.cjca.2017.12.005
   PubMed Web of Science ®Google Scholar
• Fox CS, Golden SH, Anderson C, et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the american heart association and the american diabetes association. Diabetes Care. 2015;38(9):1777–1803. doi:10.2337/dci15-0012
   PubMed Web of Science ®Google Scholar
• Namba T, Masaki N, Takase B, Adachi T. Arterial stiffness assessed by cardio-ankle vascular index. Int J Mol Sci. 2019;20(15):3664. doi:10.3390/ijms20153664
   PubMed Web of Science ®Google Scholar
• Namekata T, Shirai K, Tanabe N, et al. Estimating the extent of subclinical arteriosclerosis of persons with prediabetes and diabetes mellitus among Japanese urban workers and their families: a cross-sectional study. BMC Cardiovasc Disord. 2016;16:52. doi:10.1186/s12872-016-0230-6
   PubMed Web of Science ®Google Scholar
• Ibata J, Sasaki H, Hanabusa T, et al. Increased arterial stiffness is closely associated with hyperglycemia and improved by glycemic control in diabetic patients. J Diabetes Investig. 2013;4(1):82–87. doi:10.1111/j.2040-1124.2012.00229.x
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015;38(Supplement 1):S1–93.
   Google Scholar
• Abdul-Ghani M, DeFronzo RA, Del Prato S, Chilton R, Singh R, Ryder REJ. Cardiovascular disease and Type 2 diabetes: has the dawn of a new era arrived? Diabetes Care. 2017;40(7):813–820. doi:10.2337/dc16-2736
   PubMed Web of Science ®Google Scholar
• Elias MF, Crichton GE, Dearborn PJ, Robbins MA, Abhayaratna WP. Associations between Type 2 diabetes mellitus and arterial stiffness: a prospective analysis based on the maine-syracuse study. Pulse (Basel). 2018;5(1–4):88–98. doi:10.1159/000479560
   PubMedGoogle Scholar
• Chang S, Kim J, Sohn T, Son H, Lee J. Effects of glucose control on arterial stiffness in patients with type 2 diabetes mellitus and hypertension: an observational study. J Int Med Res. 2018;46(1):284–292. doi:10.1177/0300060517722697
   PubMed Web of Science ®Google Scholar
• Tian G, Wei W, Zhang W, et al. Increasing age associated with elevated cardio-ankle vascular index scores in patients with type 2 diabetes mellitus. J Int Med Res. 2013;41(2):435–444. doi:10.1177/0300060513477290
   PubMed Web of Science ®Google Scholar
• Sunkara N, Ahsan CH. Hypertension in diabetes and the risk of cardiovascular disease. Cardiovasc Endocrinol. 2017;6(1):33–38. doi:10.1097/XCE.0000000000000114
   PubMedGoogle Scholar
• Moreno B, de Faria AP, Ritter AMV, et al. Glycated hemoglobin correlates with arterial stiffness and endothelial dysfunction in patients with resistant hypertension and uncontrolled diabetes mellitus. J Clin Hypertension. 2018;20(5):910–917. doi:10.1111/jch.13293
   Web of Science ®Google Scholar
• Tedesco MA, Natale F, Di Salvo G, Caputo S, Capasso M, Calabró R. Effects of coexisting hypertension and type II diabetes mellitus on arterial stiffness. J Hum Hypertens. 2004;18(7):469–473. doi:10.1038/sj.jhh.1001690
   PubMed Web of Science ®Google Scholar
• de Oliveira Alvim R, Santos P, Musso MM, et al. Impact of diabetes mellitus on arterial stiffness in a representative sample of an urban Brazilian population. Diabetol Metab Syndr. 2013;5(1):45. doi:10.1186/1758-5996-5-45
   PubMedGoogle Scholar
• Navarro-Pérez J, Orozco-Beltran D, Gil-Guillen V, et al. Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: the ESCARVAL-risk study. BMC Cardiovasc Disord. 2018;18(1):180. doi:10.1186/s12872-018-0914-1
   PubMedGoogle Scholar
• World Health Organization. Waist circumference and waist-hip ratio: report of a WHO expert consultation. Geneva, 8-11 December 2008; 2011.
   Google Scholar
• Shirai K, Utino J, Otsuka K, Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb. 2006;13(2):101–107. doi:10.5551/jat.13.101
   PubMed Web of Science ®Google Scholar
• Park SY, Chin SO, Rhee SY, et al. Cardio-ankle vascular index as a surrogate marker of early atherosclerotic cardiovascular disease in Koreans with Type 2 diabetes mellitus. Diabetes Metab J. 2018;42(4):285–295. doi:10.4093/dmj.2017.0080
   PubMed Web of Science ®Google Scholar
• Kabutoya T, Kario K. Comparative assessment of cutoffs for the cardio-Ankle vascular index and brachial-ankle pulse wave velocity in a nationwide registry: a cardiovascular prognostic coupling study. Pulse (Basel). 2019;6(3–4):131–136. doi:10.1159/000489604
   PubMedGoogle Scholar
• Yingchoncharoen T, Sritara P. Cardio-Ankle vascular index in a Thai population. Pulse. 2017;4(Suppl 1):8–10. doi:10.1159/000448490
   PubMedGoogle Scholar
• Nagayama D, Imamura H, Sato Y, et al. Inverse relationship of cardioankle vascular index with BMI in healthy Japanese subjects: a cross-sectional study. Vasc Health Risk Manag. 2017;13:1–9. doi:10.2147/VHRM.S119646
   PubMed Web of Science ®Google Scholar
• Thitiwuthikiat P, Siriwittayawan D, Nuamchit T. Prehypertension and high serum uric acid increase risk of arterial stiffness. Scand J Clin Lab Invest. 2017;77(8):673–678. doi:10.1080/00365513.2017.1397287
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes-2019 abridged for primary care providers. Clin Diabetes. 2019;37(1):11–34. doi:10.2337/cd18-0105
   PubMedGoogle Scholar
• Duckworth WC. Hyperglycemia and cardiovascular disease. Curr Atheroscler Rep. 2001;3(5):383–391. doi:10.1007/s11883-001-0076-x
   PubMedGoogle Scholar
• Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–2559.
   PubMed Web of Science ®Google Scholar
• Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560–2572.
   PubMed Web of Science ®Google Scholar
• Boyne MS, Saudek CD. Effect of insulin therapy on macrovascular risk factors in type 2 diabetes. Diabetes Care. 1999;22(Suppl 3):C45–53.
   PubMedGoogle Scholar
• Sengstock DM, Vaitkevicius PV, Supiano MA. Arterial stiffness is related to insulin resistance in nondiabetic hypertensive older adults. J Clin Endocrinol Metab. 2005;90(5):2823–2827. doi:10.1210/jc.2004-1686
   PubMed Web of Science ®Google Scholar
• Llauradó G, Ceperuelo-Mallafré V, Vilardell C, et al. Advanced glycation end products are associated with arterial stiffness in type 1 diabetes. J Endocrinol. 2014;221(3):405–413. doi:10.1530/JOE-13-0407
   PubMed Web of Science ®Google Scholar
• Prasad K, Mishra M. Do advanced glycation end products and its receptor play a role in pathophysiology of hypertension? Int J Angiol. 2017;26(1):1–11. doi:10.1055/s-0037-1598183
   PubMed Web of Science ®Google Scholar
• Stehouwer CDA, Henry RMA, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia. 2008;51(4):527. doi:10.1007/s00125-007-0918-3
   PubMed Web of Science ®Google Scholar
• Ramakrishna V, Jailkhani R. Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients. Acta Diabetol. 2008;45(1):41–46. doi:10.1007/s00592-007-0018-3
   PubMed Web of Science ®Google Scholar
• Chung AW, Yang HH, Sigrist MK, et al. Matrix metalloproteinase-2 and −9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease. Cardiovasc Res. 2009;84(3):494–504. doi:10.1093/cvr/cvp242
   PubMed Web of Science ®Google Scholar
• Goncalves I, Bengtsson E, Colhoun HM, et al. Elevated plasma levels of MMP-12 are associated with atherosclerotic burden and symptomatic cardiovascular disease in subjects with Type 2 diabetes. Arterioscler Thromb Vasc Biol. 2015;35(7):1723–1731. doi:10.1161/ATVBAHA.115.305631
   PubMed Web of Science ®Google Scholar
• Aroor A, DeMarco V, Jia G, et al. The role of tissue renin-angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness. Front Endocrinol (Lausanne). 2013;4:161. doi:10.3389/fendo.2013.00161
   PubMedGoogle Scholar
• Xu C, Zarins CK, Pannaraj PS, Bassiouny HS, Glagov S. Hypercholesterolemia superimposed by experimental hypertension induces differential distribution of collagen and elastin. Arterioscler Thromb Vasc Biol. 2000;20(12):2566–2572. doi:10.1161/01.ATV.20.12.2566
   PubMed Web of Science ®Google Scholar
• Harvey A, Montezano AC, Lopes RA, Rios F, Touyz RM. Vascular fibrosis in aging and hypertension: molecular mechanisms and clinical implications. Can J Cardiol. 2016;32(5):659–668. doi:10.1016/j.cjca.2016.02.070
   PubMed Web of Science ®Google Scholar
• Ecobici M, Stoicescu C. Arterial stiffness and hypertension - which comes first? Maedica (Buchar). 2017;12(3):184–190.
   PubMedGoogle Scholar
• Yasmin MCM, Wallace S, Dakham Z, et al. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol. 2005;25(2):372. doi:10.1161/01.ATV.0000151373.33830.41
   PubMed Web of Science ®Google Scholar
• Lyle AN, Raaz U. Killing me unsoftly: causes and mechanisms of arterial stiffness. Arterioscler Thromb Vasc Biol. 2017;37(2):e1–e11. doi:10.1161/ATVBAHA.116.308563
   PubMed Web of Science ®Google Scholar
• Pietri P, Vyssoulis G, Vlachopoulos C, et al. Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension. J Hypertens. 2006;24(11):2231–2238. doi:10.1097/01.hjh.0000249701.49854.21
   PubMed Web of Science ®Google Scholar
• Mahmud A, Feely J. Arterial stiffness and the renin-angiotensin-aldosterone system. J Renin Angiotensin Aldosterone Syst. 2004;5(3):102–108. doi:10.3317/jraas.2004.025
   PubMed Web of Science ®Google Scholar
• Oh YS. Arterial stiffness and hypertension. Clin Hypertension. 2018;24:17. doi:10.1186/s40885-018-0102-8
   PubMedGoogle Scholar
• Ghazanfari Z, Haghdoost AA, Alizadeh SM, Atapour J, Zolala F. A comparison of hba1c and fasting blood sugar tests in general population. Int J Prev Med. 2010;1(3):187–194.
   PubMedGoogle Scholar